Home › Companies › ADAPTIVE BIOTECHNOLOGIES CORP. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings. Page generated November 20, 2026.
No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from ADAPTIVE BIOTECHNOLOGIES CORP. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ADAPTIVE BIOTECHNOLOGIES CORP. in the interactive database Compare manager voting policies
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
238 asset managers disclosed a vote on at least one ADAPTIVE BIOTECHNOLOGIES CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADAPTIVE BIOTECHNOLOGIES CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
78% of fund votes cast · no official result
Description as filed by funds: To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins
The 69 asset managers below reported 37,164,263 for, 10,568,153 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,956,386 | 0 | 0 | 0 | For |
| ARK ETF Trust | 7,553,921 | 0 | 0 | 0 | For |
| BlackRock | 5,227,459 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 3,403,610 | 0 | 0 | 0 | For |
| Fidelity | 2,563,497 | 0 | 0 | 274,786 | Mixed |
| Aberdeen | 0 | 0 | 0 | 1,640,384 | Withhold |
| MFS | 1,528,596 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 1,347,968 | Withhold |
| TIAA | 1,265,815 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 1,238,622 | Withhold |
| Bridge Builder Trust | 54,541 | 0 | 0 | 895,060 | Mixed |
| Charles Schwab | 926,840 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 0 | 0 | 0 | 792,975 | Withhold |
| Goldman Sachs | 745,853 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 724,091 | Withhold |
| Victory Capital | 0 | 0 | 0 | 689,287 | Withhold |
| OPTIMUM FUND TRUST | 199,713 | 0 | 0 | 291,676 | Mixed |
| JPMorgan | 456,860 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 450,386 | Withhold |
| Equitable | 314,000 | 0 | 0 | 130,769 | Mixed |
| Allspring | 0 | 0 | 0 | 321,556 | Withhold |
| Calamos | 301,659 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 0 | 291,538 | Withhold |
| Pacific Life | 258,084 | 0 | 0 | 0 | For |
| Lincoln Financial | 148,997 | 0 | 0 | 80,519 | Mixed |
Showing the 25 largest of 69 asset managers. All 69 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,956,386 | 0 | 0 | 0 | For |
| ARK ETF Trust | 7,553,921 | 0 | 0 | 0 | For |
| BlackRock | 5,227,459 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 3,403,610 | 0 | 0 | 0 | For |
| Fidelity | 2,838,283 | 0 | 0 | 0 | For |
| Aberdeen | 1,640,384 | 0 | 0 | 0 | For |
| MFS | 1,528,596 | 0 | 0 | 0 | For |
| Voya | 1,347,968 | 0 | 0 | 0 | For |
| TIAA | 1,265,815 | 0 | 0 | 0 | For |
| ALGER FUNDS | 1,238,622 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 949,601 | 0 | 0 | 0 | For |
| Charles Schwab | 926,840 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 792,975 | 0 | 0 | 0 | For |
| Goldman Sachs | 745,853 | 0 | 0 | 0 | For |
| First Trust | 724,091 | 0 | 0 | 0 | For |
| Victory Capital | 689,287 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 491,389 | 0 | 0 | 0 | For |
| JPMorgan | 456,860 | 0 | 0 | 0 | For |
| Dimensional | 450,386 | 0 | 0 | 0 | For |
| Equitable | 444,769 | 0 | 0 | 0 | For |
| Allspring | 321,556 | 0 | 0 | 0 | For |
| Calamos | 301,659 | 0 | 0 | 0 | For |
| Lord Abbett | 291,538 | 0 | 0 | 0 | For |
| Pacific Life | 258,084 | 0 | 0 | 0 | For |
| Lincoln Financial | 229,516 | 0 | 0 | 0 | For |
Fund voting reports, all 67 managers: 47,395,632 for, 67,900 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 29,993,708 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 8,896,074 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 5,757,371 | 0 | 0 | 0 | For |
| BlackRock | 4,730,646 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,831,456 | 0 | 0 | 0 | For |
| Iron Triangle Partners LP | 2,093,897 | 0 | 0 | 0 | For |
| State Street | 2,077,831 | 0 | 0 | 0 | For |
| Blue Water Life Science Advisors, LP | 2,002,839 | 0 | 0 | 0 | For |
| Voya | 1,940,385 | 0 | 0 | 0 | For |
| Victory Capital | 1,839,747 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,728,954 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,716,758 | 0 | 0 | 0 | For |
| Aberdeen | 1,640,384 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,585,567 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 1,577,055 | 0 | 0 | 0 | For |
| Nuveen | 1,284,129 | 0 | 0 | 0 | For |
| Aristotle Atlantic Partners, LLC | 1,269,754 | 0 | 0 | 0 | For |
| Charles Schwab | 927,445 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 864,272 | 0 | 0 | 0 | For |
| Northern Trust | 777,213 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 627,173 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 599,551 | 0 | 0 | 0 | For |
| Clearline Capital LP | 586,380 | 0 | 0 | 0 | For |
| Polar Asset Management Partners Inc. | 481,793 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,000 | 451,310 | 0 | 0 | Against |
Institutional-manager reports, all 187 managers: 83,803,651 for, 1,405,323 against, 76,365 withheld, 77 not voted. Showing the 25 largest; every one is in the interactive database (link above).
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: 14A Executive Compensation To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB FUND, INC. | 132,909 | 0 | 0 | 0 | For |
| Dunham Funds | 116,870 | 0 | 0 | 0 | For |
Fund voting reports, all 2 managers: 249,779 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Pier Capital, LLC | 671,404 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 671,404 for.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FORUM FUNDS II | 19,105 | 0 | 0 | 0 | For |
Fund voting reports, all 1 managers: 19,105 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 948,246 | 0 | 0 | 0 | For |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 267,796 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,216,042 for.
83% of fund votes cast · no official result
The 2 asset managers below reported 500 for, 100 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Baker Avenue Asset Management, LP | 500 | 0 | 0 | 0 | For |
| Focus Partners Wealth | 0 | 100 | 0 | 0 | Against |
Combines 3 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025; and
The 67 asset managers below reported 47,463,532 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,956,386 | 0 | 0 | 0 | For |
| ARK ETF Trust | 7,553,921 | 0 | 0 | 0 | For |
| BlackRock | 5,227,459 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 3,403,610 | 0 | 0 | 0 | For |
| Fidelity | 2,838,283 | 0 | 0 | 0 | For |
| Aberdeen | 1,640,384 | 0 | 0 | 0 | For |
| MFS | 1,528,596 | 0 | 0 | 0 | For |
| Voya | 1,347,968 | 0 | 0 | 0 | For |
| TIAA | 1,265,815 | 0 | 0 | 0 | For |
| ALGER FUNDS | 1,238,622 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 949,601 | 0 | 0 | 0 | For |
| Charles Schwab | 926,840 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 792,975 | 0 | 0 | 0 | For |
| Goldman Sachs | 745,853 | 0 | 0 | 0 | For |
| First Trust | 724,091 | 0 | 0 | 0 | For |
| Victory Capital | 689,287 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 491,389 | 0 | 0 | 0 | For |
| JPMorgan | 456,860 | 0 | 0 | 0 | For |
| Dimensional | 450,386 | 0 | 0 | 0 | For |
| Equitable | 444,769 | 0 | 0 | 0 | For |
| Allspring | 321,556 | 0 | 0 | 0 | For |
| Calamos | 301,659 | 0 | 0 | 0 | For |
| Lord Abbett | 291,538 | 0 | 0 | 0 | For |
| Pacific Life | 258,084 | 0 | 0 | 0 | For |
| Lincoln Financial | 229,516 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).
100% of fund votes cast · no official result
Description as filed by funds: Ratify Appointment of Independent Auditors To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.
The 2 asset managers below reported 249,779 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB FUND, INC. | 132,909 | 0 | 0 | 0 | For |
| Dunham Funds | 116,870 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 151,916,722 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.21% |
| 2 | ARK ETF Trust | 4.97% |
| 3 | BlackRock | 3.44% |
| 4 | Columbia Threadneedle | 2.24% |
| 5 | Fidelity | 1.87% |
| 6 | Aberdeen | 1.08% |
| 7 | MFS | 1.01% |
| 8 | Voya | 0.89% |
| 9 | TIAA | 0.83% |
| 10 | ALGER FUNDS | 0.82% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | VIKING GLOBAL INVESTORS LP | 19.74% |
| 2 | Rubric Capital Management LP | 5.86% |
| 3 | Nikko Asset Management Co., Ltd. | 3.79% |
| 4 | BlackRock | 3.11% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.86% |
| 6 | Iron Triangle Partners LP | 1.38% |
| 7 | State Street | 1.37% |
| 8 | Blue Water Life Science Advisors, LP | 1.32% |
| 9 | Voya | 1.28% |
| 10 | Victory Capital | 1.21% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 29,993,708 | 19.74% | Schedule 13G, filed May 15, 2026 |
| Viking Global Entities | 29,993,708 | 19.74% | Proxy statement (DEF 14A) |
| Rubric Capital Management LP . | 14,400,000 | 9.48% | Proxy statement (DEF 14A) |
| BlackRock | 12,229,793 | 8.05% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 11,143,428 | 7.34% | Form 13F, quarter ended March 31, 2025 |
| Nikko Asset Management Americas, Inc. | 6,833,137 | 4.50% | Schedule 13G, filed February 13, 2025 |
| ARK Investment Management LLC | 4,398,669 | 2.90% | Schedule 13G, filed June 6, 2025 |
| Chad Robins | 3,580,908 | 2.36% | Proxy statement (DEF 14A) |
| Millennium Management | 2,995,301 | 1.97% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 2,780,824 | 1.83% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 151,916,722 shares outstanding, as reported by ADAPTIVE BIOTECHNOLOGIES CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ADAPTIVE BIOTECHNOLOGIES CORP.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 238 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 872 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding advisory basis, the compensation of our named executive officers… — the reporting funds and managers cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADAPTIVE BIOTECHNOLOGIES CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ADAPTIVE BIOTECHNOLOGIES CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “ADAPTIVE BIOTECHNOLOGIES (ADPT) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/adaptive-biotechnologies-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.